Eight 31 Financial’s Johnson & Johnson JNJ Stock Holding History

Eight 31 Financial’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,886	Closed	-$457K	–	85
2024 Q1	$457K	Sell	2,886 -1,513	-34%	-$241K	0.28%	65
2023 Q4	$689K	Buy	+4,399	New	+$675K	0.42%	54

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eight 31 Financial's JNJ Position: Q2 2024 in Review

Eight 31 Financial sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 2,886 shares — an estimated $457K sold.

Eight 31 Financial first reported a position in JNJ in Q4 2023 and held it in 2 quarters. The position peaked at $689K in Q4 2023. 3,802 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

Eight 31 Financial reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
Eight 31 Financial sold 2,886 Johnson & Johnson shares in Q2 2024, an estimated $457K.
Eight 31 Financial first reported a position in Johnson & Johnson in Q4 2023 and held it in 2 quarters.
Eight 31 Financial's Johnson & Johnson position peaked at $689K in Q4 2023.
3,802 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Eight 31 Financial's 13F filing for Q2 2024, filed 14 Aug 2024.